New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Aadi Bioscience, Inc.
AADI
Shape
US Flag

NASDAQ

Unprofitable

EPS improving

Unprofitable

EPS improving

53M

Biotechnology

Next Earning date - 13 Nov 2024

53M

Biotechnology

Next Earning date - 13 Nov 2024

2.15USD
Shape0.01 ( 0.47%)
Market Open
favorite-chart

Relative Strenght

10
favorite-chart

Volume Buzz

-91%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

62%

Quote Panel

Shape
Updated October 17, 2024
1W 4.88 % 1M 14.97 % 3M 40.52 % 1Y -46.12 %

Key Metrics

Shape
  • Market Cap

    52.92M


  • Shares Outstanding

    24.61M


  • Share in Float

    17.92M


  • Dividende

    0


  • Earning Date

    13 Nov 2024


  • Price Target

    2.15


  • Average Volume

    230109


  • Beta

    0.372


  • Range

    1.21-5.7


  • Industry

    Biotechnology


  • Website

    https://aadibio.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

2.21x

P/S Ratio

0.73x

P/B Ratio

0.0

Debt/Equity

-274.8%

Net Margin

$-2.4

EPS

How AADI compares to sector?

P/E Ratio

Relative Strength

Shape

AADI

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$28M

Shape349%

2025-Revenue

$0.99

Shape-84%

2025-EPS

$23M

Shape-61%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

Piper Sandler

downgrade

Previous: Not converted

2024-08-27

Now: Neutral

Jefferies

downgrade

Previous: Buy

2024-08-21

Now: Hold

Cowen & Co.

downgrade

Previous: Not converted

2024-08-21

Now: Hold

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

N/A

-0.68
vs -1.37

Q4.22

arrow
arrow

N/A

-0.77
vs -0.77

Q1.23

arrow
arrow

N/A

-0.57
vs -0.66

Q2.23

arrow
arrow

N/A

-0.67
vs -0.73

Q3.23

arrow
arrow

N/A

-0.60
vs -0.68

Q4.23

arrow
arrow

N/A

-0.60
vs -0.77

Q1.24

arrow
arrow

N/A

-0.68
vs -0.57

Q2.24

arrow
arrow

N/A

-0.54
vs -0.67

Q3.24

arrow
arrow

N/A

-0.46
vs -0.60

Q4.24

arrow
arrow

N/A

-0.32
vs -0.60

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

NA

4.2M  vs NA

Q4.22

arrow
arrow

+423%

5.2M  vs 1M

Q1.23

arrow
arrow

+154%

5.9M  vs 2.3M

Q2.23

arrow
arrow

+80%

6.2M  vs 3.4M

Q3.23

arrow
arrow

+40%

6M  vs 4.2M

Q4.23

arrow
arrow

+21%

6.3M  vs 5.2M

Q1.24

arrow
arrow

-9%

5.4M  vs 5.9M

Q2.24

arrow
arrow

0%

6.2M  vs 6.2M

Q3.24

arrow
arrow

+11%

6.6M  vs 6M

Q4.24

arrow
arrow

+9%

6.9M  vs 6.3M

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

-8%

-0.08
vs -0.17

Q4.22

arrow
arrow

-9%

-0.09
vs -0.08

Q1.23

arrow
arrow

-9%

-0.09
vs -0.09

Q2.23

arrow
arrow

-14%

-0.14
vs -0.09

Q3.23

arrow
arrow

-14%

-0.14
vs -0.14

Q4.23

arrow
arrow

-15%

-0.15
vs -0.14

Q1.24

arrow
arrow

-20%

-0.20
vs -0.15

Q2.24

arrow
arrow

-19%

-0.19
vs -0.20

Institutionnal OwnershipShape

status-upQoQ

Q3.22

arrow
arrow

70

70
vs 69

1%

Q4.22

arrow
arrow

77

77
vs 70

10%

Q1.23

arrow
arrow

71

71
vs 77

-8%

Q2.23

arrow
arrow

68

68
vs 71

-4%

Q3.23

arrow
arrow

72

72
vs 68

6%

Q4.23

arrow
arrow

64

64
vs 72

-11%

Q1.24

arrow
arrow

61

61
vs 64

-5%

Q2.24

arrow
arrow

63

63
vs 61

3%

Earnings Growth

Latest News